secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2025-07-24T23:59:59+00:00
Accession:  0000950170-25-098429
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Aptevo shareholders approve reverse stock split and Yorkville equity issuance
-----------------------------------------------------------------------------

- Elected directors Marvin L. White (443,945 for) and John E. Niederhuber (444,661 for) to board.
- Approved reverse stock split at ratio 1:6 to 1:20, board to set timing and exact ratio.
- Approved issuance of >19.99% of outstanding shares under SEPA with YA II PN, Ltd. (Yorkville).
- Approved Third Amended and Restated 2018 Stock Incentive Plan and non-binding advisory say-on-pay.
- Ratified Baker Tilly as independent auditor for fiscal 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000095017025098429/0000950170-25-098429-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000095017025098429/apvo-20250724.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-098429

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer